Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02379559 · ClinicalTrials.gov registry record · NA
Exercise Intervention Metabolic Syndrome Prostate Cancer Black Men
A NA study, sponsored by Georgetown University.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT02379559 is a NA study that has completed, run by Georgetown University. The registered enrollment target is 10 participants.
The verdict
NCT02379559, a NA study, has completed, sponsored by Georgetown University.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
The main purpose of this study is to examine the feasibility of an exercise intervention on metabolic syndrome (MetS) components and biomarkers related to prostate cancer in Black men with MetS who are at increased risk of prostate cancer.
Interventions
- BEHAVIORAL Attention Control
- BEHAVIORAL Exercise
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2013-07 |
| Est. Completion | 2017-02-16 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02379559
The ClinicalTrials.gov registry entry for NCT02379559 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Georgetown University, which has 227 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Attention Control is the first listed.
NCT02379559 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02379559 about?
NCT02379559 is a clinical study titled "Exercise Intervention Metabolic Syndrome Prostate Cancer Black Men". The main purpose of this study is to examine the feasibility of an exercise intervention on metabolic syndrome (MetS) components and biomarkers related to prostate cancer in Black men with MetS who are at increased risk of prostate cancer.
What is the current status of trial NCT02379559?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2013-07. Estimated completion is 2017-02-16.
What interventions are being tested in trial NCT02379559?
The interventions under investigation include: Attention Control (BEHAVIORAL), Exercise (BEHAVIORAL).
Who is sponsoring clinical trial NCT02379559?
This trial is sponsored by Georgetown University, which has 227 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.